|
Volume 271, Number 38,
Issue of September 20, 1996
pp. 23284-23288
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Evidence for -Helical Conformation of an Essential N-terminal
Region in the Human Bcl2 Protein
(Received for publication, January 25, 1996, and in revised form, June 7, 1996)
Lillian C.
Lee
,
John J.
Hunter
¶
,
Anwer
Mujeeb

,
Christoph
Turck
''
and
Tristram G.
Parslow
¶
From the Departments of Pathology,
¶ Microbiology and Immunology, and Pharmaceutical Chemistry
and the '' Howard Hughes Medical Institute, University of
California, San Francisco, California 94143
A region occupying approximately 24 amino acids
near the N terminus of human Bcl2 is essential for this cytoplasmic
membrane protein's ability to inhibit apoptosis. Systematic
mutagenesis of this N-terminal region indicates that only five
hydrophobic and aromatic residues within it are specifically required
for function. Computerized secondary structure prediction, together
with circular dichroism spectroscopy of synthetic peptides, indicates
that the region encompassing these five residues has the propensity to
take on an -helical conformation in the presence of SDS micelles,
which presumably mimic the hydrophobic surfaces of cellular membranes
or polypeptides. The five critical residues are predicted to be
clustered on one face of this putative helix, where they might serve to
mediate protein-protein contacts involved in the multimerization of
Bcl2 or in the interaction of Bcl2 with other, as yet unidentified
components of the apoptotic pathway. Apparent structural homologues of
this helical motif are also present in at least some other
anti-apoptotic proteins from the Bcl2 family but not in those family
members that tend to potentiate, rather than inhibit, apoptosis.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. Katz, H. Benyamini, S. Rotem, M. Lebendiker, T. Danieli, A. Iosub, H. Refaely, M. Dines, V. Bronner, T. Bravman, et al.
Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2
PNAS,
August 26, 2008;
105(34):
12277 - 12282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Rotem, C. Katz, H. Benyamini, M. Lebendiker, D. Veprintsev, S. Rudiger, T. Danieli, and A. Friedler
The Structure and Interactions of the Proline-rich Domain of ASPP2
J. Biol. Chem.,
July 4, 2008;
283(27):
18990 - 18999.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kawatani and M. Imoto
Deletion of the BH1 Domain of Bcl-2 Accelerates Apoptosis by Acting in a Dominant Negative Fashion
J. Biol. Chem.,
May 23, 2003;
278(22):
19732 - 19742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Peherstorfer, B. Mayer, S. Boehm, A. Lukas, P. Hauser, G. Mayer, and R. Oberbauer
Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells
Am J Physiol Renal Physiol,
July 1, 2002;
283(1):
F190 - F196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, W. Holzgreve, and C. De Geyter
Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway
Hum. Mol. Genet.,
October 1, 2001;
10(21):
2329 - 2339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shimizu, T. Ide, T. Yanagida, and Y. Tsujimoto
Electrophysiological Study of a Novel Large Pore Formed by Bax and the Voltage-dependent Anion Channel That Is Permeable to Cytochrome c
J. Biol. Chem.,
April 14, 2000;
275(16):
12321 - 12325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Shimizu, A. Konishi, T. Kodama, and Y. Tsujimoto
BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death
PNAS,
March 28, 2000;
97(7):
3100 - 3105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. de Moissac, H. Zheng, and L. A. Kirshenbaum
Linkage of the BH4 Domain of Bcl-2 and the Nuclear Factor kappa B Signaling Pathway for Suppression of Apoptosis
J. Biol. Chem.,
October 8, 1999;
274(41):
29505 - 29509.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hirotani, Y. Zhang, N. Fujita, M. Naito, and T. Tsuruo
NH2-terminal BH4 Domain of Bcl-2 Is Functional for Heterodimerization with Bax and Inhibition of Apoptosis
J. Biol. Chem.,
July 16, 1999;
274(29):
20415 - 20420.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Otter, S. Conus, U. Ravn, M. Rager, R. Olivier, L. Monney, D. Fabbro, and C. Borner
The Binding Properties and Biological Activities of Bcl-2 and Bax in Cells Exposed to Apoptotic Stimuli
J. Biol. Chem.,
March 13, 1998;
273(11):
6110 - 6120.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Aritomi, N. Kunishima, N. Inohara, Y. Ishibashi, S. Ohta, and K. Morikawa
Crystal Structure of Rat Bcl-xL. IMPLICATIONS FOR THE FUNCTION OF THE Bcl-2 PROTEIN FAMILY
J. Biol. Chem.,
October 31, 1997;
272(44):
27886 - 27892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Furukawa, S. Iwase, J. Kikuchi, Y. Terui, M. Nakamura, H. Yamada, Y. Kano, and M. Matsuda
Phosphorylation of Bcl-2 Protein by CDC2 Kinase during G2/M Phases and Its Role in Cell Cycle Regulation
J. Biol. Chem.,
July 7, 2000;
275(28):
21661 - 21667.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|